NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 65219-0433-15 — Pantoprazole 40 mg intravenous injectionAI (203 hospitals, 25,358–26,015 samples)
• NDC 00378-6985-01 — SODIUM CHLORIDE 0.9 % FOR NEBULIZATIONAI (197 hospitals, 25,839–26,010 samples)
• NDC 00006-4827-01 — Chickenpox vaccine (live, injection)AI (394 hospitals, 25,451–26,009 samples)
• NDC 63323-0488-31 — Lidocaine with epinephrine local anesthetic injectionAI (108 hospitals, 25,789–26,005 samples)
• NDC 45802-0580-62 — Scopolamine 1 mg transdermal patch (3-day)AI (277 hospitals, 25,042–26,005 samples)
• NDC 00904-6570-06 — Oxybutynin chloride extended-release 5 mg tabletAI (239 hospitals, 25,517–26,003 samples)
• NDC 00591-2136-80 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (74 hospitals, 24,621–25,998 samples)
• NDC 00378-6232-01 — citalopram 20 mg tabletAI (360 hospitals, 25,448–25,988 samples)
• NDC 70069-0064-10 — Ropivacaine (preservative-free) 0.5% numbing injectionAI (217 hospitals, 25,193–25,976 samples)
• NDC 24208-0715-10 — Prednisolone sodium phosphate 1% eye dropsAI (404 hospitals, 25,111–25,975 samples)
• NDC 00085-4331-01 — Posaconazole 300 mg intravenous solutionAI (254 hospitals, 25,077–25,968 samples)
• NDC 73473-0303-70 — METRONIDAZOLE VAGINAL GELAI (198 hospitals, 25,090–25,963 samples)
• NDC 68462-0564-35 — MUPIROCIN CALCIUM 2 % TOPICAL CREAMAI (121 hospitals, 25,090–25,963 samples)
• NDC 60505-6225-00 — Brimonidine and timolol eye dropsAI (60 hospitals, 25,209–25,956 samples)
• NDC 47781-0424-47 — Fentanyl 72-hour transdermal patch, 25 mcg/hourAI (565 hospitals, 25,215–25,953 samples)
• NDC 00338-0675-04 — Potassium chloride in dextrose and saline IV solutionAI (677 hospitals, 24,396–25,953 samples)
• NDC 63323-0852-25 — Hydromorphone injection (1 mg/mL)AI (577 hospitals, 22,142–25,949 samples)
• NDC 47781-0586-56 — LABETALOL 5 MG/ML INTRAVENOUS SOLUTIONAI (224 hospitals, 24,796–25,948 samples)
• NDC 51079-0985-20 — Buspirone 5 mg tablets, 100-count blister packAI (805 hospitals, 25,060–25,942 samples)
• NDC 31722-0935-02 — albendazole 200 mg tabletAI (329 hospitals, 25,437–25,941 samples)
• NDC 00555-0779-02 — Medroxyprogesterone acetate 10 mg tabletsAI (547 hospitals, 25,139–25,931 samples)
• NDC 60687-0457-01 — Ibuprofen 600 mg tabletAI (511 hospitals, 25,046–25,928 samples)
• NDC 66794-0235-02 — Dexmedetomidine IV infusion in salineAI (107 hospitals, 25,136–25,928 samples)
• NDC 63323-0495-27 — Lidocaine (preservative-free) 2% injectionAI (699 hospitals, 22,551–25,926 samples)
• NDC 50268-0644-15 — Oxycodone and acetaminophen 5 mg/325 mg tabletAI (250 hospitals, 25,122–25,923 samples)
• NDC 65162-0465-10 — IBUPROFEN 600 MG TABLETAI (254 hospitals, 25,443–25,920 samples)
• NDC 60505-6231-00 — Cefazolin 2 gram injection vialAI (670 hospitals, 21,981–25,914 samples)
• NDC 39822-3015-01 — Nystatin topical powder 15 gramAI (182 hospitals, 25,085–25,913 samples)
• NDC 60432-0465-50 — Lidocaine 4% mucosal solutionAI (120 hospitals, 25,085–25,913 samples)
• NDC 25021-0751-11 — Pantoprazole 40 mg intravenous injectionAI (117 hospitals, 25,382–25,913 samples)
• NDC 65219-0433-01 — Pantoprazole 40 mg intravenous injectionAI (211 hospitals, 25,343–25,910 samples)
• NDC 00245-5317-01 — Potassium chloride extended-release tablet, 10 mEqAI (400 hospitals, 25,159–25,906 samples)
• NDC 00008-4001-25 — Pantoprazole 40 mg intravenous injectionAI (152 hospitals, 25,254–25,902 samples)
• NDC 63323-0578-41 — Glycopyrrolate 0.2 mg/mL injectionAI (132 hospitals, 25,109–25,901 samples)
• NDC 00338-1091-04 — Amino acid and dextrose intravenous solutionAI (184 hospitals, 25,661–25,895 samples)
• NDC 00641-6151-01 — Hydromorphone hydrochloride injection 2 mg/mLAI (518 hospitals, 17,842–25,888 samples)
• NDC 55111-0154-30 — Ondansetron 8 mg tabletAI (122 hospitals, 21,832–25,873 samples)
• NDC 63323-0659-09 — Indomethacin sodium injection, 1 mg vialAI (117 hospitals, 25,527–25,869 samples)
• NDC 00143-9284-10 — Pantoprazole 40 mg IV injectionAI (532 hospitals, 25,246–25,867 samples)
• NDC 62332-0546-05 — Timolol eye drops, 0.5% solutionAI (317 hospitals, 24,980–25,862 samples)
• NDC 71266-2003-02 — Neostigmine 5 mg/5 mL syringeAI (150 hospitals, 25,070–25,862 samples)
• NDC 23155-0512-11 — Nimodipine 30 mg capsulesAI (326 hospitals, 25,400–25,859 samples)
• NDC 00078-0855-26 — Ciprofloxacin and hydrocortisone ear dropsAI (202 hospitals, 25,006–25,852 samples)
• NDC 70069-0064-25 — Ropivacaine hydrochloride 5 mg/mL injectionAI (316 hospitals, 25,149–25,851 samples)
• NDC 60687-0487-11 — SPIRONOLACTONE 100 MG TABLETAI (307 hospitals, 25,308–25,848 samples)
• NDC 25021-0672-10 — Atracurium 10 mg/mL solution, 10 mL vialAI (125 hospitals, 25,779–25,842 samples)
• NDC 63323-0886-56 — Sodium phosphate oral solutionAI (103 hospitals, 25,341–25,827 samples)
• NDC 51079-0440-20 — Levothyroxine 50 mcg tablets, 100-count blister packAI (471 hospitals, 25,115–25,826 samples)
• NDC 65649-0303-03 — Rifaximin 550 mg tabletAI (1277 hospitals, 25,106–25,826 samples)
• NDC 60505-6149-00 — Ceftriaxone sodium injection 2 gramAI (505 hospitals, 18,013–25,825 samples)